Pharmacovigilance
Pharmacovigilance
Ana Ivanovska, MPharm,PgDip
Head of Pharmacovigilance Department
Our Pharmacovigilance professionals offer PVG support, which can include global and/or local PV services.
PV for Marketed Products
Our Pharmacovigilance professionals offer:
- Expert advice on PV system requirements
- Providing Qualified PV personnel (a QPPV, QPPV deputy, local PV contact and medically qualified personnel)
- Development, implementation and maintenance of the PV system
- Preparation and maintenance of PSMF
- Preparation and maintenance of Pharmacovigilance SOPs and other controlled quality documents
- Preparation or review of PV agreements or safety data exchange agreements with business partners
- A safety data receipt and processing
- Signal detection and evaluation
- Regular worldwide and local literature screening for case reports and other safety information
- Electronic- or paper-based reporting to EMA and European competent authorities
- Preparation of Periodic Safety Update Reports, Summary Bridging Reports, Addendum Reports, and other Aggregate Safety Reports
- Risk Management Plans
- PV trainings for PV and non-PV personnel
- Creation of XEVPRMs
- PV Audits, preparation of Corrective Action Plan, implementation of CAPA
- Labelling evaluation and variations
- Crisis management
We can also offer our support in PV for veterinary products.
PV for Clinical Trials
Clinres Farmacija offers complete drug safety development services during clinical trials including:
- Service of experienced professionals (responsible person for pharmacovigilance, and back-up),
- Registration with Eudravigilance Clinical Trial Module,
- Establishment of Standard Operating Procedures (SOPs) on clinical trial pharmacovigilance and other controlled quality documents,
- Management of cases and case processing (SAE),
- SAE medical review, MedDRA coding,
- Safety data reconciliation,
- Preparation and submission of Development Safety Update Reports,
- Preparation and submission of periodic SUSAR reports,
- Electronic reporting of Suspected Unexpected Serious Adverse Events (SUSARS),
- Reporting to Regulatory Authorities and Ethics Committees as appropriate,
- Supporting assessment of risk-benefit ratios throughout the trial and updating the Investigator Brochure as necessary,
- Developing of risk management plans in full compliance with regulations.
We offer dedicated phone and fax lines which enable you to personally contact a safety officer.